MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2026.1765851

Медицинская библиотека · Frontiers in immunology · 2026

New insights into the treatment of nasopharyngeal carcinoma in children, adolescents, and young adults: a retrospective study.

Ren Mengwei, Tian Jing, Han Mengyuan, Sun Shiran, Wang Kai, Wu Runye, Yuan Meng, Yi Junlin, Ma Fei, Li Sidan

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVE

To evaluate the efficacy, safety, and survival impacts of diverse induction chemotherapy regimens (including combination therapy with immune checkpoint inhibitors [ICIs]), radiotherapy modalities, and consolidation therapy in children, adolescents, and young adults (CAYA) with locally advanced or metastatic nasopharyngeal carcinoma (NPC).

METHODS

This multicenter retrospective study analyzed 102 CAYA NPC patients (aged 6-24 years; stage III-IVB) from two Chinese centers (January 2011-October 2024). All received induction therapy followed by concurrent chemoradiotherapy (CCRT), radiotherapy combined with concurrent anti-EGFR therapy, or radiotherapy alone, with select cases receiving consolidation (median follow-up: 22 months).

RESULTS

GP and TPF induction achieved higher objective response rates (ORR) vs. TP (GP: 68.0% vs. TP: 31.6%, P = 0.005; TPF: 89.5% vs. TP: 68.0%, P < 0.001), though no significant difference in long-term survival was observed. ICIs + chemotherapy (n=15) improved ORR (93.3% vs. 53.3%, P = 0.013) though without a demonstrable difference in survival metrics at this follow-up. In patients achieving partial response (PR) post-induction, CCRT/anti-EGFR therapy + radiotherapy improved 1-year progression-free survival (PFS: 94.5% vs. 50.0%, P < 0.001) and distant metastasis-free survival (DMFS: 97.4% vs. 50.0%, P < 0.001). For stable disease (SD) patients, multimodal therapy increased 5-year overall survival (OS: 100% vs. 66.7%, P = 0.046). Consolidation therapy (n=24) in locally advanced NPC was associated with clinical stage (P = 0.001) but not survival (P > 0.05).

CONCLUSION

TPF/GP regimens improved short-term responses with manageable toxicity. The addition of ICIs enhanced objective response rates, though survival benefits were not assessable within the limited follow-up period. CCRT demonstrated survival advantages over radiotherapy alone, especially in PR patients, while consolidation therapy showed limited benefit except in advanced subgroups. These findings, generated from a retrospective analysis, highlight the need for personalized strategies and warrant validation in larger prospective trials.

Для цитирования: Ren Mengwei, Tian Jing, Han Mengyuan, Sun Shiran, Wang Kai, Wu Runye, Yuan Meng, Yi Junlin, Ma Fei, Li Sidan. New insights into the treatment of nasopharyngeal carcinoma in children, adolescents, and young adults: a retrospective study.. Frontiers in immunology. 2026. DOI: 10.3389/fimmu.2026.1765851.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.